Control subjects(n = 25) | Patients with asthma | ||
---|---|---|---|
Stable(n = 24) | Exacerbation(n = 28) | ||
*Data are presented as mean (SE). | |||
†p<0.001 compared with patients with stable asthma. | |||
M/F | 14/11 | 12/12 | 13/15 |
Age (years)* | 38.1 (5.1) | 39.2 (5.4) | 42.2 (4.9) |
Asthma duration (years)* | – | 11.2 (2.7) | 9.8 (2.3) |
Atopic/non-atopic | 0/25 | 17/7 | 19/9 |
FEV1 (% predicted)* | – | 92.9 (1.8) | 54.0 (2.0)† |
Pao2 (kPa)* | – | 11.7 (0.1) | 9.3 (0.3)† |
Paco2 (kPa)* | – | 5.3 (0.1) | 4.4 (0.1)† |